Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AVITA Medical, Inc. | Chief Financial Officer | Common Stock | 46.5K | $578K | $12.45 | Jul 1, 2022 | Direct |
Cytek Biosciences, Inc. | Director | Restricted Stock Units | 22.5K | $125K | $5.53 | Nov 18, 2024 | Direct |
Cytek Biosciences, Inc. | Director | Common Stock | 3.64K | $20.1K | $5.53 | Nov 18, 2024 | Direct |
Cytek Biosciences, Inc. | Director | Stock Option (right to buy) | 37.9K | Jun 5, 2024 | Direct | ||
AVITA Medical, Inc. | Chief Financial Officer | Stock Options (Right to Buy) | 20.7K | Jul 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTKB | Cytek Biosciences, Inc. | Nov 18, 2024 | 2 | $0 | 4 | Nov 20, 2024 | Director |
CTKB | Cytek Biosciences, Inc. | Aug 19, 2024 | 2 | $0 | 4 | Aug 21, 2024 | Director |
CTKB | Cytek Biosciences, Inc. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
CTKB | Cytek Biosciences, Inc. | Jun 5, 2024 | 0 | $0 | 3 | Jun 7, 2024 | Director |
RCEL | AVITA Medical, Inc. | Jul 1, 2022 | 2 | $0 | 4 | Jul 6, 2022 | Chief Financial Officer |
RCEL | AVITA Medical, Inc. | Jul 6, 2021 | 2 | $0 | 4 | Sep 7, 2021 | Chief Financial Officer |
RCEL | AVITA Medical, Inc. | May 11, 2021 | 1 | $0 | 4 | May 11, 2021 | Chief Financial Officer |